Skip to main content

Table 1 Index cases were classified as new VL cases, relapsed VL cases, VL treatment failure, or PKDL

From: Detection of asymptomatic Leishmania infection in Bangladesh by antibody and antigen diagnostic tools shows an association with post–kala-azar dermal leishmaniasis (PKDL) patients

  720 contacts
N (%)
69 asymptomatic
N (%)
Median age (IQR) 27 (25) 30 (25)
Male 280 (38.9) 31 (44.9)
Occupation
 Students 248 (34.4) 23 (33.3)
 Housewives 301.68 (41.9) 26 (37.7)
Lives within the household of an index case 505 (70.1) 50 (72.5)
VL 476 (66.1) 34 (49.3)
 New VL case 429/476 (90.1) 34/34 (100.0)
 Relapsed VL case 45/476 (9.5) 0
 VL treatment failure 2/476 (0.4) 0
Post–kala azar dermal leishmaniasis (PKDL) 244 (33.9) 35 (50.7)
 Macular rash 230/244 (95.0) 33/35 (94.3)
 Macular and papular rash 4/244 (1.7) 0
 Nodular and macular rash 6/244 (2.5) 0
 Macular, nodular, and papular rash 2/244 (0.8) 1/35 (2.9)
 Rash type unknown 2/244 (0.8) 1/35 (2.9)
  1. Of the 720 contacts, 476 (66.1%) were associated with VL cases, and 244 (33.9%) were associated with PKDL cases. Of the 69 participants positive for at least one test, 34 (49.3%) were VL cases and 35 (50.7%) were PKDL cases